AbbVie's Allergan Aesthetics division has secured FDA approval for SKINVIVE by JUVÉDERM for improvement of neck appearance, marking the first filler indication specifically cleared for the neck in the U.S. market. The approval opens a new revenue stream in a category where practices have historically relied on off-label filler use, laser, or RF modalities.
AbbVie Wins FDA Approval for SKINVIVE by JUVÉDERM for Neck — First Filler Indication in Category
Allergan Aesthetics' new neck-appearance indication expands the JUVÉDERM filler portfolio beyond face and lips.

First filler indication specifically cleared for the neck in the U.S. market.
SKINVIVE is formulated with JUVÉDERM's proprietary cross-linked hyaluronic acid and is designed for subdermal injection to address skin laxity and volume loss in the neck. This approval follows SKINVIVE's earlier clearance for cheek augmentation and sits within AbbVie's broader strategy to expand JUVÉDERM's clinical footprint beyond traditional facial zones. Practices will need to update consent forms and training protocols; the indication also creates an opportunity to bundle neck treatment with existing face/lip cases.
Source: original report ↗
Frequently asked questions
Is SKINVIVE by JUVÉDERM FDA approved for the neck?
Yes, SKINVIVE by JUVÉDERM received FDA approval for improvement of neck appearance, making it the first filler indication specifically cleared for the neck in the U.S. market. It is formulated with cross-linked hyaluronic acid and designed for subdermal injection to address skin laxity and volume loss.
What indications does SKINVIVE by JUVÉDERM have?
SKINVIVE is approved for cheek augmentation and neck appearance improvement. The neck indication is the newest addition to the JUVÉDERM portfolio, expanding the product line beyond traditional facial zones like the face and lips.
Can you use regular fillers off-label for neck treatment?
Historically, practices have relied on off-label filler use, laser, or RF modalities for neck treatment since there was no FDA-approved filler specifically for that area. Now with SKINVIVE's neck approval, practices have an on-label option that eliminates the need for off-label use.
What do medspa practices need to do to offer SKINVIVE for neck treatment?
Practices will need to update consent forms and training protocols to reflect the new neck indication. The approval also creates an opportunity to bundle neck treatment with existing face and lip cases to increase case value.
How is SKINVIVE different from other JUVÉDERM products?
SKINVIVE uses JUVÉDERM's proprietary cross-linked hyaluronic acid formulation and is specifically designed for subdermal injection in areas like the neck and cheeks. Its unique formulation and approved indications differentiate it from other fillers in the JUVÉDERM portfolio.
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Seasoned Expat Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.